Grimes & Company’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $17.4M | Sell |
|
|||||
2025
Q1 | $18.3M | Sell |
|
|||||
2024
Q4 | $16.6M | Buy |
|
|||||
2024
Q3 | $14.9M | Sell |
|
|||||
2024
Q2 | $13.2M | Buy |
|
|||||
2024
Q1 | $1.27M | Buy |
|
|||||
2023
Q4 | $1.38M | Buy |
|
|||||
2023
Q3 | $1.27M | Buy |
|
|||||
2023
Q2 | $1.29M | Buy |
|
|||||
2023
Q1 | $1.39M | Sell |
|
|||||
2022
Q4 | $1.46M | Sell |
|
|||||
2022
Q3 | $1.05M | Buy |
|
|||||
2022
Q2 | $1.05M | Sell |
|
|||||
2022
Q1 | $1.01M | Buy |
|
|||||
2021
Q4 | $1.21M | Buy |
|
|||||
2021
Q3 | $1.16M | Buy |
|
|||||
2021
Q2 | $1.14M | Buy |
|
|||||
2021
Q1 | $1.07M | Buy |
|
|||||
2020
Q4 | $837K | Sell |
|
|||||
2020
Q3 | $918K | Sell |
|
|||||
2020
Q2 | $1.12M | Sell |
|
|||||
2020
Q1 | $1.11M | Buy |
|
|||||
2019
Q4 | $940K | Buy |
|
|||||
2019
Q3 | $800K | Sell |
|
|||||
2019
Q2 | $864K | Sell |
|
|||||
2019
Q1 | $859K | Sell |
|
|||||
2018
Q4 | $850K | Buy |
|
|||||
2018
Q3 | $1.05M | Sell |
|
|||||
2018
Q2 | $973K | Sell |
|
|||||
2018
Q1 | $1.15M | Buy |
|
|||||
2017
Q4 | $238K | Buy |
|
|||||
2017
Q3 | – | Sell |
|
|||||
2017
Q2 | $226K | Buy |
|
|||||
2017
Q1 | – | Sell |
|
|||||
2016
Q4 | $216K | Sell |
|
|||||
2016
Q3 | $273K | Sell |
|
|||||
2016
Q2 | $371K | Buy |
|
|||||
2016
Q1 | $357K | Sell |
|
|||||
2015
Q4 | $807K | Buy |
|
|||||
2015
Q3 | $708K | Buy |
|
|||||
2015
Q2 | $793K | Buy |
|
|||||
2015
Q1 | $214K | Buy |
|